FIND, the Global Alliance for Diagnostics and the iAssay Team Up to Develop Diagnostics
- iAssay
March 23, 2022 — A new test for Buruli ulcer is being developed under the leadership of FIND, the global alliance for diagnostics. iAssay® Inc, a privately held developer of point of care (POC) readers for remote medical diagnostics, is proud to report that the consortium has used iAssay reader model 2030 for its field studies. Read more…
Related Reading
Resource / COVID-19 / Diagnostics
AdvaMed COVID Testing Supply Registry – Weekly Report
May 14, 2022
This report outlines a key data-driven summary of the U.S. COVID testing supply.
News / COVID-19 / Diagnostics / Global & Trade / Government Affairs & Legislative
AdvaMed Welcomes the UK Government’s Commitment to Address Elective Recovery and Access to Care
February 17, 2022
The Advanced Medical Technology Association (AdvaMed), working in the United Kingdom with the Medical Technology Group (MTG) and the Association of British HealthTech Industries (ABHI), commends the recent announcement by the UK Government of aggressive polices to address access to care challenges that have been exacerbated by the COVID-19 pandemic.
News / COVID-19 / Diagnostics / Global & Trade / Government Affairs & Legislative
AdvaMed Statement on White House Request for Information on COVID-19 Test Manufacturing
February 17, 2022
Today, AdvaMed President and CEO Scott Whitaker applauded the White House’s Request for Information on policies to sustain diagnostic test manufacturing for COVID-19.
News / Diagnostics / Global & Trade / Government Affairs & Legislative
AdvaMed, Semiconductor Industry Association Convene Roundtable on Supply Chain Issues
February 16, 2022
Last week, AdvaMed President and CEO Scott Whitaker and Semiconductor Industry Association (SIA) President and CEO John Neuffer hosted a joint roundtable discussion that included dozens of industry leaders and supply chain executives from SIA and AdvaMed member companies, as well as senior officials from the Department of Commerce.
Resource / Diagnostics
AdvaMedDx 2022 Priorities
February 16, 2022
AdvaMed and AdvaMedDx have prioritized supporting MedTech’s mobilization to the pandemic to protect patients and public health.
News / Diagnostics / Global & Trade
Canadian Hospital Specialties Limited Joins AdvaMed, the World’s Leading Medical Technology Trade Association
February 10, 2022
February 9, 2022 — Canadian Hospital Specialties Limited (CHS) announced today that it has joined the Advanced Medical Technology Association (AdvaMed), the world’s leading trade association representing more than 400 medical device manufacturers around the world.
Blog / Diagnostics / Government Affairs & Legislative
MedTech Poised to Make Significant Contribution to White House Cancer Moonshot
February 3, 2022
Chairman and CEO of Edwards Lifesciences, Mike Mussallem joins AdvaMed’s Scott Whitaker to discuss the dedication of those in the industry and how policy reform can help speed up the process of getting devices to patients.
News / Diagnostics / Government Affairs & Legislative
AdvaMed Commends White House on Relaunch of Cancer Moonshot
February 2, 2022
In a letter to President Joe Biden today, AdvaMed President and CEO Scott Whitaker thanked the Administration for relaunching the Cancer Moonshot with an emphasis on cancer screening and advances in cancer testing, and he requested that the President include medtech industry leaders in an upcoming Cancer Moonshot Summit.